• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性卵巢肿瘤的相对频率:十年回顾

Relative frequency of primary ovarian neoplasms: a 10-year review.

作者信息

Koonings P P, Campbell K, Mishell D R, Grimes D A

机构信息

Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Women's Hospital, Los Angeles.

出版信息

Obstet Gynecol. 1989 Dec;74(6):921-6.

PMID:2685680
Abstract

The relative frequency of ovarian neoplasms varies according to information in different texts. In an attempt to clarify the distribution of primary ovarian neoplasms by decades of life, a 10-year retrospective review of 861 women with a postoperative diagnosis of an ovarian neoplasm was undertaken. Benign cystic teratoma was the single most common ovarian neoplasm, accounting for 44% of all neoplasms, and was 57% more frequent than benign serous tumors. Germ cell neoplasms were the most common group of benign ovarian neoplasms; epithelial neoplasms were the most common malignant neoplasm. Stromal neoplasms and neoplasms of low malignant potential were uncommon at all ages. The risk that an ovarian neoplasm was malignant increased 12-fold from ages 20-29 to 60-69. The overall risk that an ovarian neoplasm was malignant was 13% in premenopausal women and 45% in postmenopausal women.

摘要

根据不同文献中的信息,卵巢肿瘤的相对发生率有所不同。为了明确按年龄段划分的原发性卵巢肿瘤的分布情况,我们对861例术后诊断为卵巢肿瘤的女性进行了为期10年的回顾性研究。良性囊性畸胎瘤是最常见的单一卵巢肿瘤,占所有肿瘤的44%,比良性浆液性肿瘤的发生率高出57%。生殖细胞肿瘤是最常见的良性卵巢肿瘤类型;上皮性肿瘤是最常见的恶性肿瘤。基质肿瘤和低恶性潜能肿瘤在各年龄段均不常见。卵巢肿瘤为恶性的风险在20 - 29岁至60 - 69岁之间增加了12倍。绝经前女性卵巢肿瘤为恶性的总体风险为13%,绝经后女性为45%。

相似文献

1
Relative frequency of primary ovarian neoplasms: a 10-year review.原发性卵巢肿瘤的相对频率:十年回顾
Obstet Gynecol. 1989 Dec;74(6):921-6.
2
Histological pattern of ovarian tumors and their age distribution.卵巢肿瘤的组织学模式及其年龄分布。
Nepal Med Coll J. 2008 Jun;10(2):81-5.
3
Histopathological patterns of ovarian tumours seen in Lagos University Teaching Hospital: a ten year retrospective study.拉各斯大学教学医院所见卵巢肿瘤的组织病理学模式:一项十年回顾性研究。
Nig Q J Hosp Med. 2011 Apr-Jun;21(2):114-8.
4
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.性腺生殖细胞肿瘤:一篇选择性综述,重点强调鉴别诊断中的问题、新认识的问题及有争议的问题。
Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310.
5
Pattern of ovarian tumours among Malaysian women at General Hospital, Kuala Lumpur.吉隆坡总医院马来西亚女性卵巢肿瘤的发病模式。
Med J Malaysia. 1992 Jun;47(2):139-46.
6
[Hormonally-active ovarian tumors in 30 years of data (1965-1994)].30年数据(1965 - 1994年)中的激素活性卵巢肿瘤
Med Pregl. 1999 Jun-Aug;52(6-8):241-5.
7
Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.伴有黏液性上皮性肿瘤的卵巢成熟畸胎瘤:形态学异质性及与腹膜假黏液瘤的关联
Am J Surg Pathol. 2008 May;32(5):645-55. doi: 10.1097/PAS.0b013e31815b486d.
8
Relationship of ovarian neoplasms and body mass index.卵巢肿瘤与体重指数的关系。
J Reprod Med. 2005 Aug;50(8):595-602.
9
Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.绝经后妇女良性和恶性上皮性卵巢肿瘤中的血清胰岛素样生长因子(IGF)-I、IGF结合蛋白(IGFBP)-3、瘦素浓度及胰岛素抵抗
Gynecol Endocrinol. 2008 Mar;24(3):117-21. doi: 10.1080/09513590801895559.
10
Risk factors for benign serous and mucinous epithelial ovarian tumors.良性浆液性和黏液性上皮性卵巢肿瘤的危险因素。
Obstet Gynecol. 2007 Mar;109(3):647-54. doi: 10.1097/01.AOG.0000254159.75977.fa.

引用本文的文献

1
The Clinical Relevance of Distinguishing Between Simple and Complex Adnexal Cystic Structures by Ultrasound in Peri- and Postmenopause.超声鉴别围绝经期和绝经后单纯性与复杂性附件囊性结构的临床意义
Cancers (Basel). 2025 Apr 20;17(8):1370. doi: 10.3390/cancers17081370.
2
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.影响低级别浆液性卵巢癌患者生存结局的临床参数:一项国际多中心分析。
Can J Surg. 2023 Jun 27;66(3):E310-E320. doi: 10.1503/cjs.017020. Print 2023 May-Jun.
3
Diagnostic imaging of adnexal masses in pregnancy.
孕期附件包块的诊断性影像学检查
Obstet Gynecol Sci. 2023 May;66(3):133-148. doi: 10.5468/ogs.22287. Epub 2023 Mar 10.
4
Single-port laparoscopic surgery for parasitic cystic teratoma of the greater omentum and bilateral ovarian teratomas: a case report.单孔腹腔镜手术治疗大网膜寄生性囊性畸胎瘤及双侧卵巢畸胎瘤:病例报告
J Surg Case Rep. 2023 Jan 31;2023(1):rjad021. doi: 10.1093/jscr/rjad021. eCollection 2023 Jan.
5
MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.MEX3A 通过介导 p53 降解来抑制铁死亡从而促进卵巢癌细胞发生。
Cancer Res. 2023 Jan 18;83(2):251-263. doi: 10.1158/0008-5472.CAN-22-1159.
6
Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.卵巢成熟囊性畸胎瘤中由人乳头瘤病毒 16 感染引起的鳞状细胞癌:病例报告及文献复习。
Medicine (Baltimore). 2022 Sep 23;101(38):e30667. doi: 10.1097/MD.0000000000030667.
7
Impact of Optimal Therapy and Prognostic Factors in Malignant Germ Cell Tumors of Ovary: 20 Years' Institutional Experience.卵巢恶性生殖细胞肿瘤的最佳治疗效果及预后因素:20年的机构经验
Indian J Surg Oncol. 2022 Sep;13(3):633-640. doi: 10.1007/s13193-022-01537-3. Epub 2022 May 2.
8
Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma.解析由癌症相关成纤维细胞主导的免疫图谱,以研究它们在高级别浆液性卵巢癌中预测预后和指导治疗方案的潜在作用。
Front Immunol. 2022 Sep 2;13:940801. doi: 10.3389/fimmu.2022.940801. eCollection 2022.
9
The Anti-Tumor Efficacy of Verbascoside on Ovarian Cancer Facilitating CCN1-AKT/NF-κB Pathway-Mediated M1 Macrophage Polarization.毛蕊花糖苷对卵巢癌的抗肿瘤作用:促进CCN1-AKT/NF-κB信号通路介导的M1巨噬细胞极化
Front Oncol. 2022 Jun 17;12:901922. doi: 10.3389/fonc.2022.901922. eCollection 2022.
10
Comparison of Survival Outcomes According to Variant Type in High-grade Serous Ovarian Cancer.高级别浆液性卵巢癌中根据变异类型的生存结局比较。
In Vivo. 2022 Jul-Aug;36(4):1903-1910. doi: 10.21873/invivo.12910.